Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...
WASHINGTON — The FDA on Friday issued emergency approval for a smaller dose version of Pfizer's COVID-19 vaccine for use in children aged 5 to 11. The agency's decision comes just days after the ...
The U.S. Food and Drug Administration issued its full approval of the Pfizer covid-19 vaccine Monday. The move comes eight months after the Pfizer vaccine was authorized for emergency use in the ...
Pfizer says COVID vaccine protection lasts at least 6 months; Company can now seek full FDA approval
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for children 6 months through 11 years old, according to an FDA ...
With the full FDA approval of the Pfizer COVID-19 vaccine, many across the country are asking questions. Will this be a reason for more employers and schools to begin mandating vaccination? What sort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback